Ritalin And Adderall To Get Toxicology Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Review of the ADHD products by National Toxicology Program’s Center for the Evaluation of Risks to Human Reproduction is expected to take three to six months.
You may also be interested in...
“Whistleblower” Suits Should Be Encouraged By Rx Manufacturers, Sen. Grassley Says
Schering-Plough’s Claritin settlement prompts letter from Grassley to Schering and 18 other manufacturers. Educating employees about the False Claims Act and their right to file suit is a “step in the right direction” to address fraud, he says.
PBMs Object To Real-Time Prior Authorization As Part Of E-Prescribing
Medco, Express Scripts and Cigna maintain that “automated” prior authorization is not feasible because it requires a discussion with the doctor. The PBMs recommend that HHS should support electronic transmission of prior authorization “where feasible.”
E-Prescriber Access To Non-Preferred Drug Listings Is Industry Concern
Physicians should not have to scroll or click through new windows to see non-preferred and off-formulary drugs, Pfizer, J&J tell the standards subcommittee of the National Committee on Vital & Health Statistics.